Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Clinical and pathological characterization of tebentafusp-associated skin toxicity: A cohort study with 33 patients.

  • Authors : Tomsitz D; Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany. Electronic address: .; Kerl K

Subjects: Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/etiology ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/pathology ; Melanoma*/Melanoma*/Melanoma*/pathology

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Dec; Vol. 91 (6), pp. 1136-1142. Date of Electronic Publication: 2024 Aug Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration's Adverse Event Reporting System dataset.

  • Authors : Salah S; La Roche-Posay Laboratoire Dermatologique, Levallois Perret, France. Electronic address: .; Kerob D

Subjects: Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; United States Food and Drug Administration* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Nov; Vol. 91 (5), pp. 863-871. Date of Electronic Publication: 2024 Jul 20.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Dermatologic toxicities of antibody-drug conjugates.

  • Authors : Gronbeck C; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.; Hadfield MJ

Subjects: Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/adverse effects ; Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/therapeutic use ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/etiology

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Dec; Vol. 91 (6), pp. 1177-1188. Date of Electronic Publication: 2024 Aug Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Antibody-drug conjugates: A review of cutaneous adverse effects.

  • Authors : Saberi SA; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

Subjects: Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/adverse effects ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/etiology; Humans

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Nov; Vol. 91 (5), pp. 922-931. Date of Electronic Publication: 2024 Jul 22.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy.

  • Authors : Asdourian MS; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.

Subjects: Skin Diseases*/Skin Diseases*/Skin Diseases*/etiology ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/etiology ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Jun; Vol. 88 (6), pp. 1368-1370. Date of Electronic Publication: 2023 Feb Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor-induced dermatologic adverse events.

  • Authors : Singer S; Harvard Medical School, Boston, Massachusetts.; Tan SY

Subjects: Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/drug therapy ; Exanthema*/Exanthema*/Exanthema*/chemically induced; Humans

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Jun; Vol. 88 (6), pp. 1271-1281. Date of Electronic Publication: 2019 Dec Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.

  • Authors : Wongvibulsin S; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Subjects: Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/drug therapy ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/epidemiology ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/etiology

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Mar; Vol. 86 (3), pp. 563-572. Date of Electronic Publication: 2021 Apr 02.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients.

  • Authors : Phillips GS; SUNY Downstate Medical Center, Brooklyn, New York; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Subjects: Dermatitis/Dermatitis/Dermatitis/*epidemiology ; Dermatitis/Dermatitis/Dermatitis/*etiology ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*epidemiology

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2018 Jun; Vol. 78 (6), pp. 1102-1109. Date of Electronic Publication: 2017 Dec Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Editorial & Opinion

Cutaneous adverse events to immune checkpoint inhibitors in pediatric populations: A retrospective cohort study.

  • Authors : McCormack L; Dermatology Program, Boston Children's Hospital, Boston, Massachusetts; University of Massachusetts Medical School, Worcester, Massachusetts.

Subjects: Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/epidemiology ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/etiology; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*adverse effects

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Dec; Vol. 85 (6), pp. 1587-1589. Date of Electronic Publication: 2020 Nov Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Editorial & Opinion

A systematic review of eczematous eruptions in patients receiving biologic therapy.

  • Authors : Mufti A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada.; Sachdeva M

Subjects: Drug Eruptions* ; Eczema* ; Exanthema*

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Dec; Vol. 85 (6), pp. 1630-1635. Date of Electronic Publication: 2020 Dec Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
  • 1-10 of  511 results for ""Drug Eruptions""